Jiangsu Hengrui Medicine Co Ltd - Company Profile
Powered by 
All the data and insights you need on Jiangsu Hengrui Medicine Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Jiangsu Hengrui Medicine Co Ltd Strategy Report
- Understand Jiangsu Hengrui Medicine Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Jiangsu Hengrui Medicine Insights
Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.
A sample of Jiangsu Hengrui Medicine Insights data
| Headline | Published | Journalists |
|---|---|---|
| Deserunt mollit sunt Lorem laborum do id aliqua dolore | 07 Sep 2022 | Lorem |
| LoA Update: Jiangsu Hengrui Medicine’s asset SHR-1020 for bile duct cancer plummets 9 points after withdrawn Phase II | 25 Jun 2021 | William Newton |
| Chinese checkpoint inhibitors’ cost advantage provides initial edge over Merck, BMS approvals in China; other factors will influence long-term market share, experts say | 26 Apr 2019 | Manasi Vaidya,Shuan Sim |
| Hengrui Therapeutics collaborates with CRO INC for Phase I oncology study -- executive | 19 Oct 2017 | Christina Hwang |
Feature
Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.
Benefit
Drug Insights:
- Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
- Material intelligence on competitors, including breaking news
- Insight on companies’ business development needs and strategies
Outsourcing Insights:
Insight on companies’ CRO and business development needs, strategies and relationships
Value
Remove risk and uncertainty
Gain a competitive edge
Secure actionable leads
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer